Solstice Awarded High Tech Fund support
Enschede, 21 July 2021 - We are pleased to announce that we have been granted support from the High Tech Fund. This financial support will enable us to establish our GMP pilot line for our UCA cartridges and accelerate our product development and clinical trajectory. The funding will be used in conjunction with the successful investment round that was completed earlier this month. “This funding clearly demonstrates the strong backing from the Twente region to support the development and growth of the company for the benefit of patients around the world. Thereby generating highly skilled jobs in the region and further strengthening Twente as an innovative medical technology hub” said managing director Wim van Hoeve.